Clinical Trial Update: Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI) [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate the safety and effectiveness of the CorPath 200 System in percutaneous coronary interventions (PCI); results were posted after tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• CorPath 200 System

Snippet

Sponsor: Corindus Inc. | Conditions: Coronary Artery Disease, Coronary Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-08-08